Celiac Disease Drugs Market
1 STUDY COVERAGE
1.1 Celiac Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 United States Celiac Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type1
1.2.3 Type2
1.3 Market by Application1.3.1 United States Celiac Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Application 1
1.3.3 Application 2
1.4 United States Celiac Disease Drugs Sales Estimates and Forecasts 2017-20281.5 United States Celiac Disease Drugs Hydrocephalus Shunts Revenue Estimates and Forecasts 2017-2028
1.6 Study Objectives
1.7 Years Considered
2 COMPETITION BY MANUFACTURERS
2.1 United States Celiac Disease Drugs Sales by Manufacturers
2.1.1 United States Celiac Disease Drugs Sales by Manufacturers (2017-2022)2.1.2 United States Celiac Disease Drugs Sales Market Share by Manufacturers (2017-2022)
2.1.3 Top Largest Manufacturers of Celiac Disease Drugs in 2021 in United States2.2 United States Celiac Disease Drugs Revenue by Manufacturers
2.2.1 United States Celiac Disease Drugs Revenue by Manufacturers (2017-2022)2.2.2 United States Celiac Disease Drugs Revenue Market Share by Manufacturers (2017-2022)
2.2.3 United States Top Companies by Celiac Disease Drugs Revenue in 20212.3 United States Celiac Disease Drugs Sales Price by Manufacturers (2017-2022)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)2.4.2 United States Celiac Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Celiac Disease Drugs Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 UNITED STATES Celiac Disease Drugs MARKET SIZE BY REGION
3.1 Celiac Disease Drugs Market Size by Region: 2017-2028
3.1.1 United States Celiac Disease Drugs Sales by Region: 2017-20223.1.2 United States Celiac Disease Drugs Sales Forecast by Region (2023-2028)
3.1.3 United States Celiac Disease Drugs Revenue by Region: 2017-2022
3.1.4 United States Celiac Disease Drugs Revenue Forecast by Region (2023-2028)3.2 Northeast Celiac Disease Drugs Sales and Revenue Growth (2017-2028)
3.3 South Celiac Disease Drugs Sales and Revenue Growth (2017-2028)
3.4 Midwest Celiac Disease Drugs Sales and Revenue Growth (2017-2028)3.5 West Celiac Disease Drugs Sales and Revenue Growth (2017-2028)
4 MARKET SIZE BY TYPE
4.1 United States Celiac Disease Drugs Sales by Type4.1.1 United States Celiac Disease Drugs Historical Sales by Type (2017-2022)
4.1.2 United States Celiac Disease Drugs Forecasted Sales by Type (2023-2028)
4.1.3 United States Celiac Disease Drugs Sales Market Share by Type (2017-2028)4.2 United States Celiac Disease Drugs Revenue by Type
4.2.1 United States Celiac Disease Drugs Historical Revenue by Type (2017-2022)
4.2.2 United States Celiac Disease Drugs Forecasted Revenue by Type (2023-2028)4.2.3 United States Celiac Disease Drugs Revenue Market Share by Type (2017-2028)
4.3 United States Celiac Disease Drugs Price by Type
4.3.1 United States Celiac Disease Drugs Price by Type (2017-2022)4.3.2 United States Celiac Disease Drugs Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION
5.1 United States Celiac Disease Drugs Sales by Application5.1.1 United States Celiac Disease Drugs Historical Sales by Application (2017-2022)
5.1.2 United States Celiac Disease Drugs Forecasted Sales by Application (2023-2028)
5.1.3 United States Celiac Disease Drugs Sales Market Share by Application (2017-2028)5.2 United States Celiac Disease Drugs Revenue by Application
5.2.1 United States Celiac Disease Drugs Historical Revenue by Application (2017-2022)
5.2.2 United States Celiac Disease Drugs Forecasted Revenue by Application (2023-2028)5.2.3 United States Celiac Disease Drugs Revenue Market Share by Application (2017-2028)
5.3 United States Celiac Disease Drugs Price by Application
5.3.1 United States Celiac Disease Drugs Price by Application (2017-2022)5.3.2 United States Celiac Disease Drugs Price Forecast by Application (2023-2028)
6 CORPORATE PROFILE
6.1 Company16.1.1 Company 1 Corporation Information
6.1.2 Company 1 Overview
6.1.3 Company 1 in United States: Celiac Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)6.1.4 Company 1 Celiac Disease Drugs Product Introduction
6.1.5 Company 1 Recent Developments
6.2 Company 2
6.2.1 Company 2 Corporation Information
6.2.2 Company 2 Overview6.2.3 Company 2 in United States: Celiac Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
6.2.4 Company 2 Celiac Disease Drugs Product Introduction
6.2.5 Company 2 Recent Developments
6.3 Company 3
6.3.1 Company 3 Corporation Information6.3.2 Company 3 Overview
6.3.3 Company 3 in United States: Celiac Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
6.3.4 Company 3 Celiac Disease Drugs Product Introduction
6.3.5 Company 3 Recent Developments
6.4 Company 36.4.1 Company 4 Corporation Information
6.4.2 Company 4 Overview
6.4.3 Company 4 in United States: Celiac Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
6.4.4 Company 4 Celiac Disease Drugs Product Introduction
6.4.5 Company 4 Recent Developments
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Celiac Disease Drugs Industry Chain Analysis
7.2 Celiac Disease Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers7.3 Celiac Disease Drugs Production Mode & Process
7.4 Celiac Disease Drugs Sales and Marketing
7.4.1 Celiac Disease Drugs Sales Channels
7.4.2 Celiac Disease Drugs Distributors
7.5 Celiac Disease Drugs Customers
8 Celiac Disease Drugs MARKET DYNAMICS
8.1.1 Celiac Disease Drugs Industry Trends
8.1.2 Celiac Disease Drugs Market Drivers
8.1.3 Celiac Disease Drugs Market Challenges
8.1.4 Celiac Disease Drugs Market Restraints
9 KEY FINDINGS IN THE UNITED STATES Celiac Disease Drugs STUDY
10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Celiac Disease Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of First Line of Treatment
Table 3. Key Players of Second Line of Treatment
Table 4. Global Celiac Disease Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Celiac Disease Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Celiac Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Celiac Disease Drugs Market Share by Region (2017-2022)
Table 8. Global Celiac Disease Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Celiac Disease Drugs Market Share by Region (2023-2028)
Table 10. Celiac Disease Drugs Market Trends
Table 11. Celiac Disease Drugs Market Drivers
Table 12. Celiac Disease Drugs Market Challenges
Table 13. Celiac Disease Drugs Market Restraints
Table 14. Global Celiac Disease Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Celiac Disease Drugs Market Share by Players (2017-2022)
Table 16. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2021)
Table 17. Ranking of Global Top Celiac Disease Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Celiac Disease Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Celiac Disease Drugs Product Solution and Service
Table 21. Date of Enter into Celiac Disease Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Celiac Disease Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Celiac Disease Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Celiac Disease Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Celiac Disease Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Celiac Disease Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Celiac Disease Drugs Revenue Market Share by Application (2017-2022)
Table 29. Global Celiac Disease Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Celiac Disease Drugs Revenue Market Share by Application (2023-2028)
Table 31. North America Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Celiac Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Celiac Disease Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Roche Company Detail
Table 42. Roche Business Overview
Table 43. Roche Celiac Disease Drugs Product
Table 44. Roche Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 45. Roche Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Celiac Disease Drugs Product
Table 49. Merck Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Celiac Disease Drugs Product
Table 54. Johnson & Johnson Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. BiolineRx Company Detail
Table 57. BiolineRx Business Overview
Table 58. BiolineRx Celiac Disease Drugs Product
Table 59. BiolineRx Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 60. BiolineRx Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Celiac Disease Drugs Product
Table 64. Pfizer Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Innovate Biopharmaceuticals Company Detail
Table 67. Innovate Biopharmaceuticals Business Overview
Table 68. Innovate Biopharmaceuticals Celiac Disease Drugs Product
Table 69. Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 70. Innovate Biopharmaceuticals Recent Development
Table 71. ImmusanT Company Detail
Table 72. ImmusanT Business Overview
Table 73. ImmusanT Celiac Disease Drugs Product
Table 74. ImmusanT Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 75. ImmusanT Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Celiac Disease Drugs Product
Table 79. Novartis Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Bristol-Myers Squibb Company Detail
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Celiac Disease Drugs Product
Table 84. Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Immunomedics Company Detail
Table 87. Immunomedics Business Overview
Table 88. Immunomedics Celiac Disease Drugs Product
Table 89. Immunomedics Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
Table 90. Immunomedics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Celiac Disease Drugs Market Share by Type: 2021 VS 2028
Figure 2. First Line of Treatment Features
Figure 3. Second Line of Treatment Features
Figure 4. Global Celiac Disease Drugs Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Others Case Studies
Figure 9. Celiac Disease Drugs Report Years Considered
Figure 10. Global Celiac Disease Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Celiac Disease Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Celiac Disease Drugs Market Share by Region: 2021 VS 2028
Figure 13. Global Celiac Disease Drugs Market Share by Players in 2021
Figure 14. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2021
Figure 16. North America Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Celiac Disease Drugs Market Share by Country (2017-2028)
Figure 18. United States Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Celiac Disease Drugs Market Share by Country (2017-2028)
Figure 22. Germany Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Celiac Disease Drugs Market Share by Region (2017-2028)
Figure 30. China Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Celiac Disease Drugs Market Share by Country (2017-2028)
Figure 38. Mexico Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Celiac Disease Drugs Market Share by Country (2017-2028)
Figure 42. Turkey Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Roche Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 45. Merck Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 47. BiolineRx Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 49. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 50. ImmusanT Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 51. Novartis Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 53. Immunomedics Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
